Endovia Health Sciences Book Value Per Share Growth & History (EDVA)
Endovia Health Sciences's book value per share was -$20.42 for fiscal 2025.
View full Endovia Health Sciences company overviewEndovia Health Sciences annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | -$20.42 | $24.22 | — |
| 2024 | 2024-12-31 | -$44.64 | -$24.41 | — |
| 2023 | 2023-12-31 | -$20.23 | -$56.53 | — |
| 2022 | 2022-12-31 | $36.30 | -$5.95 | −14.09% |
| 2021 | 2021-12-31 | $42.26 | $112.97 | — |
| 2020 | 2020-12-31 | -$70.71 | $35.99 | — |
| 2019 | 2019-12-31 | -$106.71 | -$106.60 | — |
| 2018 | 2018-12-31 | -$0.11 | $2.99 | — |
| 2017 | 2017-12-31 | -$3.10 | -$4.84 | — |
| 2016 | 2016-12-31 | $1.74 | $1.81 | — |
| 2015 | 2015-12-31 | -$0.07 | $0.92 | — |
| 2014 | 2014-12-31 | -$0.99 | $1.95 | — |
| 2013 | 2013-12-31 | -$2.94 | $1.63 | — |
| 2012 | 2012-12-31 | -$4.56 | $1.00 | — |
| 2011 | 2011-12-31 | -$5.56 | — | — |
Endovia Health Sciences quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$21.01 | -$41.90 | — |
| Q1 2026 | 2026-03-31 | -$21.61 | $20.55 | — |
| Q4 2025 | 2025-12-31 | -$20.42 | $24.22 | — |
| Q3 2025 | 2025-09-30 | $16.23 | $55.32 | — |
| Q2 2025 | 2025-06-30 | $20.88 | $58.25 | — |
| Q1 2025 | 2025-03-31 | -$42.17 | -$7.87 | — |
| Q4 2024 | 2024-12-31 | -$44.64 | -$24.41 | — |
| Q3 2024 | 2024-09-30 | -$39.08 | -$36.63 | — |
| Q2 2024 | 2024-06-30 | -$37.37 | -$52.21 | — |
| Q1 2024 | 2024-03-31 | -$34.30 | -$63.87 | — |
| Q4 2023 | 2023-12-31 | -$20.23 | -$56.53 | — |
| Q3 2023 | 2023-09-30 | -$2.45 | -$42.77 | — |
| Q2 2023 | 2023-06-30 | $14.84 | -$34.35 | −69.83% |
| Q1 2023 | 2023-03-31 | $29.57 | -$33.73 | −53.29% |
| Q4 2022 | 2022-12-31 | $36.30 | -$5.95 | −14.09% |
| Q3 2022 | 2022-09-30 | $40.32 | -$8.49 | −17.40% |
| Q2 2022 | 2022-06-30 | $49.19 | -$19.05 | −27.92% |
| Q1 2022 | 2022-03-31 | $63.31 | $51.90 | +454.87% |
| Q4 2021 | 2021-12-31 | $42.26 | $112.97 | — |
| Q3 2021 | 2021-09-30 | $48.82 | $50.36 | — |
| Q2 2021 | 2021-06-30 | $68.24 | $83.22 | — |
| Q1 2021 | 2021-03-31 | $11.41 | $25.16 | — |
| Q4 2020 | 2020-12-31 | -$70.71 | $35.99 | — |
| Q3 2020 | 2020-09-30 | -$1.55 | $375.89 | — |
| Q2 2020 | 2020-06-30 | -$14.98 | -$12.38 | — |
| Q1 2020 | 2020-03-31 | -$13.75 | -$11.37 | — |
| Q4 2019 | 2019-12-31 | -$106.71 | -$106.60 | — |
| Q3 2019 | 2019-09-30 | -$377.43 | -$377.93 | — |
| Q2 2019 | 2019-06-30 | -$2.60 | -$3.23 | — |
| Q1 2019 | 2019-03-31 | -$2.38 | -$0.13 | — |
| Q4 2018 | 2018-12-31 | -$0.11 | $2.99 | — |
| Q3 2018 | 2018-09-30 | $0.50 | -$0.74 | −59.86% |
| Q2 2018 | 2018-06-30 | $0.63 | $0.90 | — |
| Q1 2018 | 2018-03-31 | -$2.25 | -$2.79 | — |
| Q4 2017 | 2017-12-31 | -$3.10 | -$4.84 | — |
| Q3 2017 | 2017-09-30 | $1.24 | $0.53 | +74.91% |
| Q2 2017 | 2017-06-30 | -$0.27 | -$1.52 | — |
| Q1 2017 | 2017-03-31 | $0.54 | -$2.22 | −80.36% |
| Q4 2016 | 2016-12-31 | $1.74 | $1.81 | — |
| Q3 2016 | 2016-09-30 | $0.71 | $3.39 | — |
| Q2 2016 | 2016-06-30 | $1.25 | $3.02 | — |
| Q1 2016 | 2016-03-31 | $2.76 | — | — |
| Q4 2015 | 2015-12-31 | -$0.07 | $0.92 | — |
| Q3 2015 | 2015-09-30 | -$2.68 | -$3.15 | — |
| Q2 2015 | 2015-06-30 | -$1.77 | -$1.35 | — |
| Q4 2014 | 2014-12-31 | -$0.99 | $1.95 | — |
| Q3 2014 | 2014-09-30 | $0.47 | $3.03 | — |
| Q2 2014 | 2014-06-30 | -$0.43 | $4.80 | — |
| Q1 2014 | 2014-03-31 | -$2.45 | $2.43 | — |
| Q4 2013 | 2013-12-31 | -$2.94 | $1.63 | — |
| Q3 2013 | 2013-09-30 | -$2.56 | — | — |
| Q2 2013 | 2013-06-30 | -$5.23 | — | — |
| Q1 2013 | 2013-03-31 | -$4.88 | — | — |
| Q4 2012 | 2012-12-31 | -$4.56 | — | — |
Endovia Health Sciences book value per share trends
Over the last five fiscal years, Endovia Health Sciences's book value per share increased from -$70.71 to -$20.42, a change of $50.30. The latest reported quarter, Q2 2026, shows -$21.01.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Endovia Health Sciences source filings ↗